within Pharmacolibrary.Drugs.ATC.L;

model L03AA15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.12 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,
    adminCount     = 1,
    Vd             = 0.0075,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Balugrastim is a long-acting recombinant granulocyte colony-stimulating factor (G-CSF) approved in some countries for the prevention of chemotherapy-induced neutropenia. It is a fusion protein of G-CSF and human serum albumin, designed for enhanced half-life and reduced dosing frequency, but is not widely available or approved in all regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated based on class characteristics and published clinical summaries for adult cancer patients receiving chemotherapy. Published studies directly reporting compartmental PK modeling data are not available.</p><h4>References</h4><ol><li><p>Gladkov, O, et al., &amp; Avisar, N (2016). A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel. <i>The oncologist</i> 21(1) 7–15. DOI:<a href=&quot;https://doi.org/10.1634/theoncologist.2015-0152&quot;>10.1634/theoncologist.2015-0152</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26668251/&quot;>https://pubmed.ncbi.nlm.nih.gov/26668251</a></p></li><li><p>Avisar, N, et al., &amp; Pukac, L (2015). First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy. <i>Cancer chemotherapy and pharmacology</i> 75(5) 929–939. DOI:<a href=&quot;https://doi.org/10.1007/s00280-015-2703-1&quot;>10.1007/s00280-015-2703-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25740691/&quot;>https://pubmed.ncbi.nlm.nih.gov/25740691</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L03AA15;
